Efficacy of fragmin/protamine microparticles containing fibroblast growth factor-2 (F/P MPs/FGF-2) to induce collateral vessels in a rabbit model of hindlimb ischemia

Journal of Vascular Surgery

Volumn 54, Issue 3, 2011, Pages 791-798

  Horio, Takuya ^a   Fujita, Masanori ^a   Tanaka, Yoshihiro ^a   Ishihara, Masayuki ^a   Kishimoto, Satoko ^b   Nakamura, Shingo ^a   Hase, Kazuo ^a   Maehara, Tadaaki ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^b JAPAN SOCIETY FOR THE PROMOTION OF SCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD31 ANTIGEN; DALTEPARIN; FIBROBLAST GROWTH FACTOR 2; PROTAMINE; SMOOTH MUSCLE ANTIBODY;

ANGIOGENESIS; ANGIOGRAPHY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD FLOW; BLOOD PRESSURE; COMPARATIVE STUDY; CONTROLLED STUDY; CRITICAL LIMB ISCHEMIA; DRUG EFFICACY; FEMORAL ARTERY; HISTOLOGY; LIMB ISCHEMIA; MALE; NONHUMAN; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ACTINS; ANALYSIS OF VARIANCE; ANGIOGENESIS INDUCING AGENTS; ANIMALS; ANTICOAGULANTS; ANTIGENS, CD31; BLOOD PRESSURE; CAPILLARIES; CHEMISTRY, PHARMACEUTICAL; COLLATERAL CIRCULATION; DALTEPARIN; DISEASE MODELS, ANIMAL; DRUG CARRIERS; DRUG COMPOUNDING; FIBROBLAST GROWTH FACTOR 2; HEPARIN ANTAGONISTS; HINDLIMB; IMMUNOHISTOCHEMISTRY; INJECTIONS, INTRAMUSCULAR; ISCHEMIA; LASER-DOPPLER FLOWMETRY; MALE; MUSCLE, SKELETAL; NEOVASCULARIZATION, PHYSIOLOGIC; PARTICLE SIZE; PROTAMINES; RABBITS; REGIONAL BLOOD FLOW; TIME FACTORS;

EID: 80955177077     PISSN: 07415214     EISSN: 10976809     Source Type: Journal    
DOI: 10.1016/j.jvs.2011.02.060     Document Type: Article

References (38)

1. G.P. Fadini, C. Agostini, and A. Avogaro Autologous stem cell therapy for peripheral arterial disease meta-analysis and systematic review of the literature Atherosclerosis 209 2010 10 17
2. Standards of Practice Committee of the Society of Cardiovascular and Interventional Radiology Guidelines for percutaneous transluminal angioplasty Radiology 177 1990 619 626
3. R.J. Valentine, S.I. Myers, M.H. Inman, J.R. Roberts, and G.P. Clagett Late outcome of amputees with premature atherosclerosis Surgery 119 1996 487 493 (Pubitemid 26141022)
4. W.R. Hiatt Medical treatment of peripheral arterial disease and claudication N Engl J Med 344 2001 1608 1621 (Pubitemid 32479915)
5. L. Norgren, W.R. Hiatt, J.A. Dormandy, M.R. Nehler, K.A. Harris, and F.G. Fowkes Inter-society consensus for the management of peripheral arterial disease (TASC II) J Vasc Surg 45 Suppl 1 2007 S5 S67
6. N. van Royen, J.J. Piek, I. Buschmann, I. Hoefer, M. Voskuil, and W. Schaper Stimulation of arteriogenesis: a new concept for the treatment of arterial occlusive disease Cardiovasc Res 49 2001 532 542
7. W. Schaper, and D. Scholz Factors regulating arteriogenesis Arterioscler Thromb Vasc Biol 23 2003 1143 1151 (Pubitemid 36871267)
8. S. Nakamura, Y. Kanatani, S. Kishimoto, S. Nakamura, C. Ohno, and T. Horio Controlled release of FGF-2 using fragmin/protamine microparticles and effect on neovascularization J Biomed Mater Res A 91 2009 814 823
9. S. Nakamura, S. Kishimoto, S.-I. Nakamura, M. Nambu, M. Fujita, and Y. Tanaka Fragmin/protamine microparticles as cell carriers to enhance viability of adipose-derived stromal cells and their subsequent effect on in vivo neovascularization J Biomed Mater Res 92A 2010 1614 1622
10. K. Ouriel Peripheral arterial disease Lancet 358 2001 1257 1264 (Pubitemid 33010855)
11. P. Carmeliet Mechanisms of angiogenesis and arteriogenesis Nat Med 6 2000 389 395 (Pubitemid 30208155)
12. P. Cuevas, F. Carceller, S. Ortega, M. Zazo, I. Nieto, and G. Giménez-Gallego Hypotensive activity of fibroblast growth factor Science 254 1991 1208 1210 (Pubitemid 21917455)
13. S.E. Epstein, S. Fuchs, Y.F. Zhou, R. Baffour, and R. Kornowski Therapeutic interventions for enhancing collateral development by administration of growth factors: basic principles, early results and potential hazards Cardiovasc Res 49 2001 532 542 (Pubitemid 32146416)
14. M.F. Cté, G. Laroche, E. Gagnon, P. Chevallier, and C.J. Doillon Denatured collagen as support for a FGF-2 delivery system: physicochemical characterizations and in vitro release kinetics and bioactivity Biomaterials 25 2004 3761 3772 (Pubitemid 38327065)
15. K. Kawai, S. Suzuki, Y. Tabata, Y. Ikada, and Y. Nishimura Accelerated tissue regeneration through incorporation of basic fibroblast growth factor-impregnated gelatin microspheres into artificial dermis Biomaterials 21 2000 489 499 (Pubitemid 30067585)
16. S. Young, M. Wong, Y. Tabata, and A.G. Mikos Gelatin as a delivery vehicle for the controlled release of bioactive molecules J Control Release 109 2005 256 274 (Pubitemid 41737269)
17. R. Baffour, J. Berman, J.L. Garb, S.W. Rhee, J. Kaufman, and P. Friedmann Enhanced angiogenesis and growth of collaterals by in vivo administration of recombinant basic fibroblast growth factor in a rabbit model of acute lower limb ischemia: dose-response effect of basic fibroblast growth factor J Vasc Surg 16 1992 181 191
18. C. DeBlois, M.F. Cté, and C.J. Doillon Heparin-fibroblast growth factor-fibrin complex: in vitro and in vivo applications to collagen-based materials Biomaterials 15 1994 665 672
19. M. Tanihara, Y. Suzuki, E. Yamamoto, A. Noguchi, and Y. Mizushima Sustained release of basic fibroblast growth factor and angiogenesis in a novel covalently crosslinked gel of heparin and alginate J Biomed Mater Res 56 2001 216 221 (Pubitemid 32520696)
20. A. Marui, Y. Tabata, S. Kojima, M. Yamamoto, K. Tambara, and T. Nishina A novel approach to therapeutic angiogenesis for patients with critical limb ischemia by sustained release of basic fibroblast growth factor using biodegradable gelatin hydrogel: an initial report of the phase I-IIa study Circ J 71 2007 1181 1186 (Pubitemid 47195331)
21. T. Hashimoto, H. Koyama, T. Miyata, A. Hosaka, Y. Tabata, and T. Takato Selective and sustained delivery of basic fibroblast growth factor (bFGF) for treatment of peripheral arterial disease: results of a phase I trial Eur J Vasc Endovasc Surg 38 2009 71 75
22. M. Ishihara, and K. Ono Structure and function of heparin and heparan sulfate: heparinoid library and modification of FGF-activities Trends Glycosci Glycotech 10 1998 223 233
23. M. Ishihara Biosynthesis Structure, and biological activity of basic FGF binding domains of heparan sulfate Trends Glycosci Glycotech 5 1993 343 354
24. M. Salmivirta, K. Lidholt, and U. Lindahl Heparan sulfate: a piece of information FASEB J 10 1996 1270 1279 (Pubitemid 26307512)
25. U. Lindahl, K. Lidholt, D. Spillmann, and L. Kjellén More to "heparin" than anticoagulation Thromb Res 75 1994 1 32
26. J. Hirsh, T.E. Warkentin, R. Raschke, C. Granger, E.M. Ohman, and J.E. Dalen Heparin and low-molecular-weight heparin, mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety Chest 114 1998 489S 510S (Pubitemid 28535777)
27. R) at the site of activation of the coagulation system in man Haemost T 73 1995 439 443
28. M. Pan, J.S. Lezo, A. Medina, M. Romero, E. Hernandez, and J. Segura In-laboratory removal of femoral sheath following protamine administration in patients having intracoronary stent implantation Am J Cardiol 80 1997 1336 1338 (Pubitemid 27513336)
29. S. Takeshita, L.P. Zheng, E. Brogi, M. Kearney, L.Q. Pu, and S. Bunting Therapeutic angiogenesis A single intra-arterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hindlimb model J Clin Invest 93 1994 662 670
30. N. Tokunaga, N. Nagaya, M. Shirai, E. Tanaka, H. Ishibashi-Ueda, and M. Harada-Shiba Adrenomedullin gene transfer induces therapeutic angiogenesis in a rabbit model of chronic hindlimb ischemia: benefits of a novel nonviral vector, gelatin Circulation 109 2004 526 531 (Pubitemid 38168517)
31. C.J. Longland The collateral circulation of the limb Ann R Coll Surg Engl 13 1953 161 176
32. N. Yamada, W. Li, A. Ihaya, T. Kimura, K. Morioka, and T. Uesaka Platelet-derived endothelial cell growth factor gene therapy for limb ischemia J Vasc Surg 44 2006 1322 1328 (Pubitemid 44828401)
33. G.L. Tang, D.S. Chang, R. Sarkar, R. Wang, and L.M. Messina The effect of gradual or acute arterial occlusion on skeletal muscle blood flow, arteriogenesis and inflammation in rat hindlimb ischemia J Vasc Surg 41 2005 312 320 (Pubitemid 40342484)
34. M. Takikawa, S. Nakamura, S. Nakamura, M. Nambu, M. Ishihara, and M. Fujita Enhancement of vascularization and granulation tissue formation by growth factors in human platelet-rich plasma-containing fragmin/protamine microparticles J Biomed Mater Res B Appl Biomater 97 2011 373 380
35. S.P. Hopkins, J.P. Bilgrin, R.L. Sims, B. Bowman, D.L. Donovan, and S.P. Schmidt Controlled delivery of vascular endothelial growth factor promotes neovascularization and maintains limb function in rabbit model of ischemia J Vasc Surg 27 1998 886 894
36. D.W. Leung, G. Cachianes, W.J. Kuang, D.V. Goeddel, and N. Ferrara Vascular endothelial growth factor is a secreted angiogenic mitogen Science 246 1989 1306 1309 (Pubitemid 20066716)
37. C. Bauters, T. Asahara, L.P. Zheng, S. Takeshita, S. Bunting, and N. Ferrara Site-specific therapeutic angiogenesis after systemic administration of vascular endothelial growth factor J Vasc Surg 21 1995 314 324
38. E.R. Edelman, E. Mathiowitz, R. Langer, and M. Klagsbrun Controlled and modulated release of basic fibroblast growth factor Biomaterials 12 1991 619 626